Mark Alan Goldberg, Director at Blueprint Medicines Corp (BPMC), sold 5,455 shares at $115.00 ($627K) on 2020-12-11, disclosed to the SEC on 2020-12-15.
Open-market sale of $627k BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2020-12-22 | $654K | — | Filing → |
| BPMC | SELL | 2020-12-03 | $600K | — | Filing → |
| BPMC | SELL | 2020-10-21 | $573K | — | Filing → |